Your browser doesn't support javascript.
loading
Medical Therapy to Prevent or Slow Progression of Aortic Stenosis: Current Evidence and Future Directions.
Chong, Travis; Lan, Nick S R; Courtney, William; He, Albert; Strange, Geoff; Playford, David; Dwivedi, Girish; Hillis, Graham S; Ihdayhid, Abdul Rahman.
Afiliação
  • Chong T; From the Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.
  • Lan NSR; Harry Perkins Institute of Medical Research, Perth, Australia.
  • Courtney W; From the Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.
  • He A; Harry Perkins Institute of Medical Research, Perth, Australia.
  • Strange G; Internal Medicine, Medical School, The University of Western Australia, Perth, Australia.
  • Playford D; Internal Medicine, Medical School, The University of Western Australia, Perth, Australia.
  • Dwivedi G; Department of Cardiology, Royal Perth Hospital, Perth, Australia.
  • Hillis GS; From the Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.
  • Ihdayhid AR; Harry Perkins Institute of Medical Research, Perth, Australia.
Cardiol Rev ; 2023 Mar 24.
Article em En | MEDLINE | ID: mdl-36961371
ABSTRACT
Degenerative aortic stenosis is a growing clinical problem owing to the high incidence in an aging population and its significant morbidity and mortality. Currently, aortic valve replacement remains the only treatment. Despite promising observational data, pharmacological management to slow or halt progression of aortic stenosis has remained elusive. Nevertheless, with a greater understanding of the mechanisms which underpin aortic stenosis, research has begun to explore novel treatment strategies. This review will explore the historical agents used to manage aortic stenosis and the emerging agents that are currently under investigation.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article